Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
주식 순위 #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
주가
$0.0009
마지막 동기화: 2025-05-27
시가총액
$1.15K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Arch Therapeutics, Inc. (ARTH)

카테고리

Arch Therapeutics, Inc. (ARTH)의 발행 주식 수
June 2024 기준 발행 주식 수: 4.44M
Arch Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 4.44M입니다. September 2022 말 기준 회사는 1.20M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Arch Therapeutics, Inc. (ARTH)의 발행 주식 수 기록 (2011 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 4.44M 44.57%
2023 3.07M 156.27%
2022 1.20M 9.05%
2021 1.10M 16.99%
2020 940.26K 13.05%
2019 831.70K 8.92%
2018 763.56K 7.00%
2017 713.61K 17.50%
2016 607.31K 49.23%
2015 406.97K 20.60%
2014 337.46K 105.18%
2013 164.48K 482.71%
2012 28.23K -52.21%
2011 59.07K 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
253.90M 5,612.85%
US
62.19M 1,299.20%
NL
- -
CH
0.00 -100.00%
BE
- -
KR